Pluto Labs (CEO Kim Geum-soon) announced on the 2nd that it will renew and launch the high blood pressure treatment drug ‘Salacache 40mg, 80mg’ in November by reducing the dosage size.

PlutoLabs new drug for gastroesophageal reflux disease, K-Cap, demonstrated the competitiveness of a domestic new drug by presenting the latest research results at the largest academic conference in Korea where domestic and foreign gastroenterology experts gathered.

PlutoLabs introduced two new types of multivitamin sticks (▲plum flavor ▲mango flavor) in line with the peak holiday season. After adding ‘L-Arginine’ and ‘Vitamin B group’ ingredients last March, we plan to provide more diverse options to consumers by releasing two new flavors.

PlutoLabs vitamin sticks are being sold in all large duty-free stores in Korea, expanding contact with global customers.

Pluto Labs (CEO Kim Geum-soon) announced on the 13th that the ‘Heotgaesu EX Night Crow Edition’ introduced with Wemade sold out early at its own mall, Newteen Mall, and was ‘completely sold out’.

Pluto Labs, a biopharmaceutical company, received product approval for a comprehensive nutritional solution with an increased ratio of omega-3. This product is used for patients who have difficulty eating and who need nutritional support through intravenous injections. HK InnoN, which has approximately doubled its total infusion solution production since the completion of the new Osong infusion plant, plans to lead growth in the high value-added comprehensive nutritional infusion solution market based on this new product.